Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Share-based Compensation (2016 - 2025)

HealthLynked (HLYK) has disclosed Share-based Compensation for 10 consecutive years, with $4694.0 as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation rose 107.86% to $4694.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $223632.0, a 171.74% increase, with the full-year FY2024 number at $210333.0, down 30.81% from a year prior.
  • Share-based Compensation was $4694.0 for Q3 2025 at HealthLynked, down from $5267.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $335860.0 in Q4 2022 to a low of -$161722.0 in Q3 2022.
  • A 5-year average of $89999.4 and a median of $88101.0 in 2023 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: plummeted 242.14% in 2022, then surged 163.09% in 2024.
  • HealthLynked's Share-based Compensation stood at $167731.0 in 2021, then skyrocketed by 100.24% to $335860.0 in 2022, then crashed by 76.63% to $78507.0 in 2023, then soared by 163.09% to $206545.0 in 2024, then tumbled by 97.73% to $4694.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Share-based Compensation are $4694.0 (Q3 2025), $5267.0 (Q2 2025), and $7126.0 (Q1 2025).